Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-24 @ 7:24 PM
NCT ID:
NCT00133003
Eligibility Criteria:
Inclusion Criteria:
* Patients with acute coronary syndromes
* Pretreatment (2 hours) with high loading dose (600 mg) clopidogrel
* Significant angiographic lesions amenable to and requiring a PCI
* Written informed consent
Exclusion Criteria:
* ST-segment elevation acute myocardial infarction within 48 hours from symptom onset
* Hemodynamic instability
* Pericarditis
* Malignancies with life expectancy less than one year
* Increased risk of bleeding
* Oral anticoagulation therapy with coumarin derivative within 7 days
* Recent use of GPIIb/IIIa inhibitors within 14 days
* Severe uncontrolled hypertension \>180 mmHg unresponsive to therapy
* Relevant hematologic deviations: hemoglobin \< 100g/L or hematocrit \< 34%; platelet count \< 100 x 10\^9/L or platelet count \> 600 x 10\^9/L.
* Known allergy to the study medication
* Pregnancy (present or suspected)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00133003
Study Brief:
Protocol Section:
NCT00133003